These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 7616719)

  • 21. [Ulcer surgery and anti-ulcer agents. Changes in surgical activities and sale of anti-ulcer agents in Nord-Trøndelag 1975-89].
    Haaverstad R; Moen OO; Kannelønning KS; Line PD; Wibe A; Bjerkeset T
    Tidsskr Nor Laegeforen; 1994 Mar; 114(8):904-7. PubMed ID: 7910707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Surgery of peptic ulcer 10 years after the introduction of anti-H2 agents].
    Bartolotta M; Carditello A
    Ann Gastroenterol Hepatol (Paris); 1988; 24(3):107-9. PubMed ID: 2899990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The course of benign gastric ulcer; results of a follow-up study].
    Herweijer AW
    Ned Tijdschr Geneeskd; 1990 May; 134(21):1063. PubMed ID: 1973269
    [No Abstract]   [Full Text] [Related]  

  • 24. [Histamine 2 receptor antagonists in the treatment of gastric ulcer].
    Avella J; Pounder RE; Matos-Villalobos M
    G E N; 1975; 30(1-2):115-23. PubMed ID: 16809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs.
    McCarthy DM
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):755-73. PubMed ID: 11566039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medical and surgical treatment of chronic gastric ulcer.
    Kelly KA; Malagelada JR
    Clin Gastroenterol; 1984 May; 13(2):621-34. PubMed ID: 6146418
    [No Abstract]   [Full Text] [Related]  

  • 27. [Influence of anti-H2-receptors on the surgery of peptic ulcer].
    Cavallesco NG; Morsiani E; Lupi L; Dalla Valle GB; Fogli L; Belcastro S; Pampolini M; Pollice S; Santini A
    Minerva Chir; 1987 Oct; 42(19):1495-7. PubMed ID: 2891086
    [No Abstract]   [Full Text] [Related]  

  • 28. Simple closure and follow up H2 receptor antagonists for perforated peptic ulcer--immediate survival and symptomatic outcome.
    Abbasakoor F; Attwood SE; McGrath JP; Stephens RB
    Ir Med J; 1995; 88(6):207-10. PubMed ID: 8575920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gastric ulcers: investigations and treatment.
    Lane MR; Lee SP
    Compr Ther; 1984 Dec; 10(12):24-31. PubMed ID: 6151443
    [No Abstract]   [Full Text] [Related]  

  • 30. Are there indications for intravenous acid-inhibition in the prevention and treatment of upper GI bleeding?
    Geus WP
    Scand J Gastroenterol Suppl; 2000; (232):10-20. PubMed ID: 11232484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Indications for elective surgery of stomach ulcer. A physician's views].
    Rune S
    Ugeskr Laeger; 1989 Mar; 151(13):814-6. PubMed ID: 2718263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of benign, giant gastric ulcers.
    Welch JP; Hammond JG; Nissen CW
    Am Surg; 1992 May; 58(5):300-4. PubMed ID: 1622011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacology and clinical effects of acid determination in ulcer hemorrhage].
    Schepp W
    Bildgebung; 1993 Apr; 60 Suppl 1():41-4. PubMed ID: 8104063
    [No Abstract]   [Full Text] [Related]  

  • 34. [Is gastric and duodenal ulcer drug-treatable or surgical disease?].
    Fedele E
    Chir Ital; 1997; 49(1-2):5-8. PubMed ID: 12743869
    [No Abstract]   [Full Text] [Related]  

  • 35. [Influence of H2-blocking drugs on the surgical therapy of peptic ulcer].
    Procacciante F; Pronio A; Perri S; Di Nardo A; Montesani C; Citone G; Catani M; Ribotta G
    Minerva Chir; 1987 Oct; 42(19):1491-4. PubMed ID: 2891085
    [No Abstract]   [Full Text] [Related]  

  • 36. High IgE serum levels and "peptic" ulcers: clinical and functional approach.
    De Lazzari F; Mancin O; Plebani M; Venturi C; Battaglia G; Vianello F; Galliani EA; Di Mario F; Naccarato R
    Ital J Gastroenterol; 1994; 26(1):7-11. PubMed ID: 7912969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Recent progress in diagnosis and treatment of digestive diseases. I. Chronic gastritis and peptic ulcer. 3. Drug treatment of peptic ulcer disease-including maintenance therapy in the prevention of recurrence].
    Ohshiba S
    Nihon Naika Gakkai Zasshi; 1988 Nov; 77(11):1646-50. PubMed ID: 2907909
    [No Abstract]   [Full Text] [Related]  

  • 38. [Optimization of the treatment of stomach ulcer in patients subjected to perforated gastroduodenal ulcer closure].
    Lelianov AD; Budrin VA; Novikov AS; Guseva ED; Nesterov AA; Kirsov PP
    Eksp Klin Gastroenterol; 2007; (5):81-5, 165. PubMed ID: 18389603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Conservative treatment of gastric ulcer].
    Lux G; Rösch W
    Med Klin; 1980 Aug; 75(18):638-44. PubMed ID: 6106882
    [No Abstract]   [Full Text] [Related]  

  • 40. [Epidemiological behavior of perforated peptic ulcer before and after the introduction of the antisecretory drug therapy. Our experience].
    Sacco R; Giovanelli A; Giuliano L; Piazzalunga D; Poletti EM; Arrigoni F; Cassinelli GB
    Minerva Chir; 1995 Oct; 50(10):871-8. PubMed ID: 8684634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.